BioMedWire Stocks

Finnish Study Suggests Exercise Plays Smaller Role in Longevity

Common knowledge coupled with numerous polls on lifestyle and longevity indicate that exercise generally contributes to longer lives. Physicians consistently encourage their patients to exercise regularly, and many experts contend that the modern sedentary lifestyle has significantly contributed to poor health and reduced lifetimes.

However, a recent Finnish Twins Cohort Study report has suggested that exercise may not be as integral to longevity as previously thought. The report notes that “leisure time physical activity” has little direct effect on lifespan, questioning the conventional knowledge that incorporating exercise into your lifestyle can help you live longer.

Generally, an individual’s lifespan is determined by a mix of factors that include genetics, disabilities, wealth, education, environment and lifestyle factors such as diet and whether or not you exercise. Exercise has been linked to longevity, especially in the modern age where sedentary lifestyles coupled with high-calorie diets have contributed to historic rates of obesity, which is known to lower lifespans.

However, while we know that the average person is more likely to live longer if they exercise, science still hasn’t quantified how much exercise contributes to longevity compared to other factors. Research that involves twins is instrumental in determining just how impactful exercise is because it allows researchers to analyze how exercise and lack of exercise can affect two individuals with extremely similar or identical genetics.

Researchers from Finland’s University of Jyväskylä used pertinent data from exercise questionnaires that were issued to same-sex adult twins in 1975, 1981 and 1990 and connected it with death records collected up to 2020. While the most active individuals had a 24% lower death rate compared to the least physically active, the effect was smaller than previous studies had found. Furthermore, only the least physically active 10% of the study group was exposed to the most significant risk.

Analysis of the participants’ biological age found that the least and most active individuals seemed biologically older than the rest of the cohort. The researchers found that the connection between exercise and longevity was reduced when they accounted for lifestyle factors such as body mass index, alcohol consumption and smoking, resulting in a 9% difference in death rates between the most active and least active groups.

Furthermore, there was no statistically significant difference between the death rates of the highly active and moderately active groups. This means that a pair of twins with the same alcohol use, BMI and smoking history would have a relatively similar life expectancy even if their exercise levels were very different. The study indicates that while exercise is tied to increased longevity, its role may not be as significant as previously surmised.

As companies such as Clene Inc. (NASDAQ: CLNN) work to bring to market treatments aimed at reviving mitochondrial health, the quest to boost longevity will have some proven approaches patients can leverage.

NOTE TO INVESTORS: The latest news and updates relating to Clene Inc. (NASDAQ: CLNN) are available in the company’s newsroom at https://ibn.fm/CLNN

About BioMedWire

BioMedWire (“BMW”) is a specialized communications platform with a focus on the latest developments in the Biotechnology (BioTech), Biomedical Sciences (BioMed) and Life Sciences sectors. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled recognition and brand awareness.

BMW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from BioMedWire, “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer

BioMedWire
San Francisco, CA
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is powered by IBN

Chris@BMW

Share
Published by
Chris@BMW

Recent Posts

The Global Market for Brain Tumor Treatments Will Reach $7.15 Billion by 2035

The global market for brain tumor treatments is experiencing significant transformation powered by advances in…

2 days ago

New Blood Test Shows Potential in Revolutionizing Early Parkinson’s Detection

A team of researchers has developed a “cost-effective” and simple blood test with the potential…

4 days ago

Nutriband Inc. (NASDAQ: NTRB) Is ‘One to Watch’

Nutriband’s AVERSA technology has the potential to improve the safety profile of transdermal drugs susceptible…

4 days ago

Nutriband Inc. (NASDAQ: NTRB) Leading the Way in Transformative Partnerships Formed in Growing Pharma Sector

Strategic partnerships embrace opportunities to foster innovation, streamline processes and ultimately improve the lives of…

6 days ago

Adageis Helps Medical Providers Track and Build Revenue Through Efficient Application of Value-Based Care

Adageis provides clinics and medical groups with AI-powered tools to track financial outcomes tied to…

1 week ago

Blocking an Enzyme in Melanoma Patients Could Overcome Resistance to Immunotherapy

Approximately 65% of patients diagnosed with melanoma are unresponsive to immunotherapy. New research suggests that…

1 week ago